23.3. Analysis.
Comparison 23: Sensitivity analysis 3: excluding studies with unclear or high risk of bias on allocation concealment, Outcome 3: Rate of falls ‐ cholinesterase inhibitor vs placebo
Official websites use .gov
A
.gov website belongs to an official
government organization in the United States.
Secure .gov websites use HTTPS
A lock (
) or https:// means you've safely
connected to the .gov website. Share sensitive
information only on official, secure websites.